People: Forward Pharma A/S (FWP.OQ)
17 Apr 2019
Mr. Joel D. Sendek is Chief Financial Officer of the Forward Pharma A/S. Mr. Sendek joins the Company from Stifel Financial Corp. where he served as Managing Director, Biotechnology and led the firm's healthcare equity research group. Mr. Sendek has more than 20 years of experience in the life sciences sector and is widely recognized in the investment community and the corporate world for his broad biotechnology expertise and proprietary insight, including a previous #1 ranking for "Stock Picking" in The Wall Street Journal's Best on the Street Survey. Mr. Sendek also spent 12 years with Lazard Capital Markets, where he established the firm's healthcare equity research effort. Prior to his career in equity research, Mr. Sendek served as a Senior Director in Corporate Development at Progenics Pharmaceuticals and as an investment banking analyst at Goldman Sachs. Mr. Sendek holds a B.A. in Biochemistry from Rice University.
|Total Annual Compensation,||--|
|Restricted Stock Awards,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|